RxDoctor Payments Data

Sarah Jeney, MD

Urogynecology and Reconstructive Pelvic Surgery · Albuquerque, NMNPI 1710306899

Payments from drug & device makers

$2,914in general payments, 2019–2025

Across 24 payments — averaging $121.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • Coloplast$794
  • Teleflex LLC$350
  • Axonics, Inc.$299
  • Medtronic$251
  • Boston Scientific$67
  • plus $34 from 2 others

What the payments were for

  • Speaking & faculty fees$35012%
  • Travel & lodging$53618%
  • Food & beverage$1,01035%
  • Education$1,00935%
  • Entertainment$90%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical3$1,120
Coloplast4$794
Teleflex LLC1$350
Axonics, Inc.4$299
Medtronic(2 entities)7$251
Boston Scientific3$67
Femselect Inc.1$25
Optos, Inc.1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few urogynecology and reconstructive pelvic surgery providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$21,489
Medicare patients
58
Services billed
167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron13$5,833
Estradiol31$1,702
Cephalexin15$197

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Albuquerque

Where these figures come from

Is this you, or does something look wrong? →